Valentina Cambiano

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Long-term trends in adherence to antiretroviral therapy from start of HAART
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK
    AIDS 24:1153-62. 2010
  2. ncbi 'Test-and-treat': the end of the HIV epidemic?
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, London, UK
    Curr Opin Infect Dis 24:19-26. 2011
  3. ncbi Modelling the impact of treatment with individual antiretrovirals
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, London, UK
    Curr Opin HIV AIDS 6:124-30. 2011
  4. ncbi Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Royal Free Campus, UCL Royal Free Campus, London, UK
    AIDS 24:1561-7. 2010
  5. ncbi Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy
    Tomas Doyle
    Department of Virology, Royal Free Hampstead NHS Trust, and Department of Virology, UCL Medical School, London, United Kingdom
    Clin Infect Dis 54:724-32. 2012
  6. ncbi Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic
    Andrew N Phillips
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 8:e55312. 2013
  7. ncbi Projected life expectancy of people with HIV according to timing of diagnosis
    Fumiyo Nakagawa
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London, UK
    AIDS 26:335-43. 2012
  8. ncbi Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
    Andrew N Phillips
    Department of Infection and Population Health, UCL, UK
    AIDS 25:843-50. 2011
  9. ncbi Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring
    Viktor von Wyl
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    PLoS ONE 7:e42834. 2012

Detail Information

Publications9

  1. ncbi Long-term trends in adherence to antiretroviral therapy from start of HAART
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK
    AIDS 24:1153-62. 2010
    ..We aimed to investigate long-term trends in highly active antiretroviral therapy (HAART) adherence to identify the main predictors and to evaluate whether participants experience periods of low adherence (<or=60%)...
  2. ncbi 'Test-and-treat': the end of the HIV epidemic?
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, London, UK
    Curr Opin Infect Dis 24:19-26. 2011
    ..Antiretroviral therapy (ART) has been shown to dramatically reduce viral load which is strongly associated with the risk of transmission, therefore there is the potential to reduce HIV transmissions with ART...
  3. ncbi Modelling the impact of treatment with individual antiretrovirals
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, London, UK
    Curr Opin HIV AIDS 6:124-30. 2011
    ..The focus of our attention is models which explicitly model specific effects of individual antiretroviral drugs...
  4. ncbi Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Royal Free Campus, UCL Royal Free Campus, London, UK
    AIDS 24:1561-7. 2010
    ..Understanding of the interplay between plasma HIV RNA level and CD4 cell count depletion in untreated infection remains incomplete...
  5. ncbi Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy
    Tomas Doyle
    Department of Virology, Royal Free Hampstead NHS Trust, and Department of Virology, UCL Medical School, London, United Kingdom
    Clin Infect Dis 54:724-32. 2012
    ..Current viral load (VL) assays show increased sensitivity, but the significance of RNA detection <50 copies/mL is unclear...
  6. ncbi Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic
    Andrew N Phillips
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 8:e55312. 2013
    ....
  7. ncbi Projected life expectancy of people with HIV according to timing of diagnosis
    Fumiyo Nakagawa
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London, UK
    AIDS 26:335-43. 2012
    ..Our aims were to estimate the life expectancy of an HIV-infected MSM living in a developed country with extensive access to ART and healthcare, and to assess the effect of late diagnosis on life expectancy...
  8. ncbi Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
    Andrew N Phillips
    Department of Infection and Population Health, UCL, UK
    AIDS 25:843-50. 2011
    ..There is concern that antiretroviral therapy (ART) use with only clinical monitoring for failure will result in high rates of transmission of virus with resistance to drugs currently in use...
  9. ncbi Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring
    Viktor von Wyl
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    PLoS ONE 7:e42834. 2012
    ..We conducted a cost-effectiveness analysis with emphasis on emerging patterns of drug resistance upon treatment failure and their impact on second-line therapy...